ELMD - Electromed, Inc.

NYSE American - Nasdaq Real Time Price. Currency in USD

Electromed, Inc.

500 Sixth Avenue NW
New Prague, MN 56071
United States

IndustryMedical Devices
Full Time Employees115

Key Executives

NameTitlePayExercisedYear Born
Ms. Kathleen S. SkarvanCEO, Pres & Director420.43kN/A1956
Mr. Jeremy T. Brock CPACFO, Principal Accounting Officer & Financial Controller260.32kN/A1979
Mr. John KowalczykVP of SalesN/AN/AN/A
Mr. William J. George J.D.Sec.N/AN/A1949
Mr. William KalbDirector of SalesN/AN/AN/A
Amounts are as of December 31, 2017 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products in the United States and internationally. The company offers SmartVest airway clearance system that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to patients with compromised pulmonary function; and SmartVest SQL System that provides advanced generator programmability and an enhanced pause feature with save, lock, and restore functionality. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers working in intensive care units; and Aerobika, an oscillating positive expiratory pressure device. The company offers its products for patients with chronic lung issues, including bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was founded in 1992 and is headquartered in New Prague, Minnesota.

Corporate Governance

Electromed, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.